Suntech Signs Silicon Agreement with REC

Suntech Power Holdings Co., Ltd. (NYSE: STP), a leading manufacturers of photovoltaic (PV) cells and modules, has entered into a five-year silicon purchase $180 million agreement with Renewable Energy Corporation ASA (Oslo Stock Exchange: REC), the world’s largest manufacturer of multicrystalline silicon wafers for solar applications. “This agreement will enable Suntech to further reduce spot market purchases of raw materials and improve our cost competitiveness in the future,” said Dr. Zhengrong Shi, Suntech’s chairman and CEO. “This agreement also enhances our strategic relationships with the world leading silicon and wafer manufacturers.” The 5-year agreement is structured as a take-or-pay contract with a pre-determined fixed price that decreases on an annual basis. This price reduction curve will provide Suntech with wafers with an average cost measurably below spot market prices. The delivery of wafers under the contract is expected to begin in the first quarter of 2007.

Read More

OPEC to Keep Oil Prices Low to Discourage Alternative Fuel Use

OPEC announced late last week that they were planning on cutting oil production by 1.2 million barrels per day to keep costs of crude at about $60 per barrel. This cut, according to the National Ethanol Vehicle Coalition, is designed to raise the cost of gasoline while keeping it low enough to be more attractive than alternative fuel prices. “It’s unfortunate that OPEC feels they can control the vision of this country and the destiny relative to alternative fuels,” exclaimed Curtis Donaldson, Chairman of the National Ethanol Vehicle Coalition. OPEC expects to keep the price of gasoline at about $2.25 per gallon. The price is high enough for OPEC to invest in future production capacity but low enough to allow economic growth and deter a flood of alternative fuels. U.S. oil prices set a record high in July of this year topping at $78.40 a barrel and averaging record high fuel costs. Alternative fuel pricing, including E85. “OPEC feels that they can manage the price of gasoline to a point where increasing the production of E85 and providing it at more locations across the country will become less attractive. It will be disappointing if we allow this to happen when […]

Read More

Ballard Continues Losses in Q3

Ballard Power Systems (TSX:BLD.TO)(NASDAQ:BLDP), developer of fuel cells, announced continuing losses for the third quarter, but the company says they are “on track.” “In the third quarter we continued to demonstrate solid progress against our corporate objectives for 2006,” said John Sheridan, Ballard’s President and Chief Executive Officer. “Traction is now clearly evident in nearer-term fuel cell market opportunities, as shown by our progress in the residential cogeneration and materials handling markets, with the achievement of our annual goals in both markets. At the same time, our continued commitment to disciplined financial management is evidenced by our year-over-year reduction in operating cash consumption of 57% to $10.6 million.” – Revenues of $14.1 million versus $16.1 million for the same period in 2005 – Product and service revenues of $8.9 million increased $1.3 million (17%) year over prior year quarter – As expected, engineering development revenue of $5.2 million decreased $3.4 million (40%) year over prior year quarter, primarily due to the timing of Ballard’s next-generation automotive technical milestones – Reduced normalized net loss(1) of $17.7 million, an 18% improvement from $21.5 million in 2005 – Reduced operating cash consumption(2) of $10.6 million, a 57% improvement from $24.4 million in 2005 […]

Read More

Martek Wins Patent Infringement Case

Martek Biosciences Corporation (Nasdaq: MATK) announced that a jury in the U.S. District Court in Wilmington, Delaware, has returned a verdict favorable to Martek in its patent infringement suit against Lonza Ltd., Nutrinova Inc. and Nutrinova Nutrition Specialties & Food Ingredients GmbH. The jury found that Lonza infringed all the asserted claims and found that Lonza had acted willfully in its infringement of one of the patents. The verdict does not involve Martek’s core infant formula patents. Martek expects Lonza to appeal the jury’s decision. Martek intends to ask the Court for permanent injunctive relief to prohibit Lonza’s continuing infringement of the patents. “We are gratified the jury found that Martek’s patents pertaining to omega-3 DHA products and processes are valid and enforceable and that Lonza’s actions infringe on those patents. The verdict further demonstrates both the Company’s resolve to vigorously defend our intellectual property portfolio and the strength of Martek’s patent portfolio in the U.S. marketplace,” said Steve Dubin, CEO of Martek. Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the development of DHA omega-3 products. Website: [sorry this link is no longer available]     

Read More